oxprenolol has been researched along with Immunoblastic Lymphadenopathy in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
Excerpt | Relevance | Reference |
---|---|---|
"The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed." | 1.27 | Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. ( Ben Arieh, Y; Brenner, B; Green, J; Nagler, A; Rosenbaum, H; Tatarsky, I, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brenner, B | 1 |
Green, J | 1 |
Rosenbaum, H | 1 |
Ben Arieh, Y | 1 |
Nagler, A | 1 |
Tatarsky, I | 1 |
1 other study available for oxprenolol and Immunoblastic Lymphadenopathy
Article | Year |
---|---|
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
Topics: Angina Pectoris; Humans; Immunoblastic Lymphadenopathy; Oxprenolol; Pancytopenia; Prednisone; Primar | 1985 |